Tree extract tested for liver and kidney safety
NCT ID NCT07189143
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a dietary supplement made from silver fir branches (Belinal®) is safe for the liver and kidneys. Fifteen healthy adults took 900 mg daily for 14 days, and researchers measured blood markers of liver and kidney function. The goal was to see if the extract causes any harm, not to treat a disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Silver fir branch extract (Belinal®)
- What this could lead to
- If safe, this could support the use of silver fir extract as a dietary supplement without harming liver or kidneys.
- What could go wrong
- This is a very small, early safety study with only 15 healthy people. It cannot prove benefits or detect rare side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
15 people
The number who actually took part.
- Started
-
Aug 2018
- Finished
-
Oct 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy adult volunteers * Age 37-55 years * Both sexes (male and female) * Willingness to comply with study protocol and attend all study visits * Signed informed consent Exclusion Criteria: * Known acute or chronic illness * Use of any medications other than occasional analgesics (none were used by participants) * Use of dietary supplements prior to or during the study * Known mental illness (e.g., depression, psychosis, severe alcoholism, drug abuse) * Consumption of more than 2 alcohol units per day (20 g ethanol, equivalent to \~2 dl wine, 5 dl beer, or 0.3 dl brandy) * Participation in other research studies concurrently
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dietary supplement are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Ljubljana
Ljubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New sedative candidate goes Head-to-Head with propofol in early human test
- Can a Room-Temperature dairy drink build muscle?
- New injection MWN117 tested for safety in obesity
- Can a new drug avoid the high? soticlestat put to the test
- Liver trouble changes how drugs work: scientists test soticlestat
- Can a hard cycling sprint change a Heart-Calming peptide?